Evidence map›Paper›PMID 35721740›Full record

ArticleFrontiers in endocrinology2022

Human Ovarian Follicles Xenografted in Immunoisolating Capsules Survive Long Term Implantation in Mice.

Margaret A Brunette, Hadrian M Kinnear, Prianka H Hashim, Colleen L Flanagan, James R Day, Marilia Cascalho, Vasantha Padmanabhan, Ariella Shikanov

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Unlocking Transplant Tolerance with Biomaterials.Advanced healthcare materials · 2025
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Margaret A BrunetteDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
Hadrian M KinnearProgram in Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI, United States.
Prianka H HashimDepartment of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, United States.
Colleen L FlanaganDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
James R DayDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
Marilia CascalhoDepartment of Surgery, University of Michigan, Ann Arbor, MI, United States.
Vasantha PadmanabhanDepartment of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, United States.
Ariella ShikanovDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
University of Michigan–Ann Arbor · US

Funding

MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Marie Sylvia O'Neill · 2011 to 2026
$21.3M
Tissue Engineering and RegenerationT32DE007057 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID H. KOHN · 1985 to 2026
$17.3M
CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
Career Training in Reproductive BiologyT32HD079342 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Suzanne M MOENTER · 2014 to 2026
$2.3M
Engineering an immuno-isolating hydrogel for restoring ovarian endocrine functionR01HD104173 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHIKANOV, ARIELLA · 2021 to 2025
$2.0M
Engineering an immuno-isolating hydrogel for restoring ovarian endocrine functionR01EB022033 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHIKANOV, ARIELLA · 2016 to 2019
$1.5M
Reversibility of Testosterone-Induced Reproductive Changes in Adult Female MiceF30HD100163 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KINNEAR, HADRIAN MYLES · 2019 to 2022
$178k
NIBIB NIH HHS R01 EB022033NICHD NIH HHS F30 HD100163NICHD NIH HHS R01 HD104173NICHD NIH HHS T32 HD079342NIDCR NIH HHS T32 DE007057NIEHS NIH HHS P30 ES017885NIGMS NIH HHS T32 GM007315NIGMS NIH HHS T32 GM007863
6 · The paper itself

Abstract

Female pediatric cancer survivors often develop Premature Ovarian Insufficiency (POI) owing to gonadotoxic effects of anticancer treatments. Here we investigate the use of a cell-based therapy consisting of human ovarian cortex encapsulated in a poly-ethylene glycol (PEG)-based hydrogel that replicates the physiological cyclic and pulsatile hormonal patterns of healthy reproductive-aged women. Human ovarian tissue from four donors was analyzed for follicle density, with averages ranging between 360 and 4414 follicles/mm

Indexed as

Ovarian FolliclePrimary Ovarian InsufficiencyAdultAnimalsCapsulesChildCryopreservationFemaleHumansMiceCapsuleshuman ovarieshydrogelsimmunoisolationpoly (ethylene glycol)xenografts

Identifiers

PMID35721740
PMCPMC9205207
OpenAlexW4281680559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.